Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer

Despite neoadjuvant/conversion chemotherapy, the prognosis of cT4a/bN+ gastric cancer is poor. Immune checkpoint inhibitors (ICIs) and antiangiogenic agents have shown activity in late-stage gastric cancer, but their efficacy in the neoadjuvant/conversion setting is unclear. In this single-armed, ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Song, Yu, Wenbin, Xie, Fei, Luo, Haitao, Liu, Zhimin, Lv, Weiwei, Shi, Duanbo, Yu, Dexin, Gao, Peng, Chen, Cheng, Wei, Meng, Zhou, Wenhao, Wang, Jiaqian, Zhao, Zhikun, Dai, Xin, Xu, Qian, Zhang, Xue, Huang, Miao, Huang, Kai, Wang, Jian, Li, Jisheng, Sheng, Lei, Liu, Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810618/
https://www.ncbi.nlm.nih.gov/pubmed/36596787
http://dx.doi.org/10.1038/s41467-022-35431-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810618/
https://www.ncbi.nlm.nih.gov/pubmed/36596787
http://dx.doi.org/10.1038/s41467-022-35431-x

Ejemplares similares